QSS
CCXI

Quantitative Systematic Strategies’s ChemoCentryx, Inc. CCXI Stock Holding History

Quantitative Systematic Strategies’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,249
Closed -$884K – 708
2021
Q1 		$884K Sell
17,249
-3,566
-17% -$215K 0.14% 258
2020
Q4 		$1.29M Buy
20,815
+1,919
+10% +$110K 0.18% 178
2020
Q3 		$1.04M Buy
18,896
+1,951
+12% +$105K 0.18% 171
2020
Q2 		$975K Buy
16,945
+2,330
+16% +$127K 0.19% 172
2020
Q1 		$587K Buy
+14,615
New +$621K 0.48% 68

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantitative Systematic Strategies's CCXI Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 17,249 shares — an estimated $884K sold.

Quantitative Systematic Strategies first reported a position in CCXI in Q1 2020 and held it in 5 quarters. The position peaked at $1.29M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 17,249 ChemoCentryx, Inc. shares in Q2 2021, an estimated $884K.
  • Quantitative Systematic Strategies first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 5 quarters.
  • Quantitative Systematic Strategies's ChemoCentryx, Inc. position peaked at $1.29M in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.